Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas Total Liabilities 2010-2024 | HYPMY

Hypermarcas total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  
Hypermarcas Annual Total Liabilities
(Millions of US $)
2023 $2,602
2022 $2,538
2021 $1,850
2020 $1,554
2019 $813
2018 $626
2017 $749
2016 $767
2015 $2,379
2014 $2,740
2013 $2,528
2012 $2,980
2011 $4,014
2010 $2,814
2009 $1,448
Hypermarcas Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $2,462
2024-06-30 $2,557
2024-03-31 $2,736
2023-12-31 $2,602
2023-09-30 $2,636
2023-06-30 $2,576
2023-03-31 $2,252
2022-12-31 $2,538
2022-09-30 $2,299
2022-06-30 $2,175
2022-03-31 $2,005
2021-12-31 $1,850
2021-09-30 $1,984
2021-06-30 $1,692
2021-03-31 $1,577
2020-12-31 $1,554
2020-09-30 $1,447
2020-06-30 $1,228
2020-03-31 $749
2019-12-31 $813
2019-09-30 $555
2019-06-30 $502
2019-03-31 $505
2018-12-31 $626
2018-09-30 $527
2018-06-30 $507
2018-03-31 $546
2017-12-31 $749
2017-09-30 $599
2017-06-30 $820
2017-03-31 $674
2016-12-31 $767
2016-09-30 $1,055
2016-06-30 $1,130
2016-03-31 $1,099
2015-12-31 $2,379
2015-09-30 $2,029
2015-06-30 $2,322
2015-03-31 $2,181
2014-12-31 $2,740
2014-09-30 $2,732
2014-06-30 $2,618
2014-03-31 $2,410
2013-12-31 $2,528
2013-09-30 $2,751
2013-06-30 $2,857
2013-03-31 $2,848
2012-12-31 $2,980
2012-09-30 $3,050
2012-06-30 $3,359
2012-03-31 $3,601
2011-12-31 $4,014
2011-09-30 $4,315
2011-06-30 $4,354
2011-03-31 $3,784
2010-12-31 $2,814
2010-09-30 $2,241
2010-06-30 $1,811
2010-03-31 $1,624
2009-12-31 $1,448
2009-09-30 $890
2009-06-30 $722
2009-03-31 $698
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.591B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $88.594B 33.24
Zoetis (ZTS) United States $72.088B 26.90
Daiichi Sankyo, - (DSNKY) Japan $45.227B 23.01
Takeda Pharmaceutical (TAK) Japan $45.151B 8.98
Sandoz Group AG (SDZNY) Switzerland $19.811B 0.00
Summit Therapeutics (SMMT) United States $18.760B 0.00
Merck (MKKGY) Germany $18.016B 14.91
United Therapeutics (UTHR) United States $14.019B 12.40
Shionogi (SGIOY) Japan $13.305B 13.33
Neurocrine Biosciences (NBIX) United States $11.918B 40.82
IPSEN (IPSEY) France $9.397B 0.00
Orion OYJ (ORINY) Finland $8.215B 22.22
Corcept Therapeutics (CORT) United States $7.650B 62.19
Stevanato Group S.p.A (STVN) Italy $7.165B 43.81
Madrigal Pharmaceuticals (MDGL) United States $6.678B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.337B 0.00
Grifols, S.A (GRFS) Spain $5.315B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Soleno Therapeutics (SLNO) United States $3.865B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.120B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.907B 10.18
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.356B 12.88
BioCryst Pharmaceuticals (BCRX) United States $2.164B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.111B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.886B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.757B 0.00
Guardian Pharmacy Services (GRDN) United States $1.624B 0.00
Indivior (INDV) United States $1.564B 6.63
Evotec AG (EVO) Germany $1.481B 0.00
Dyne Therapeutics (DYN) United States $1.428B 0.00
ARS Pharmaceuticals (SPRY) United States $1.305B 166.12
Ocular Therapeutix (OCUL) United States $1.177B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.110B 21.95
Harrow (HROW) United States $0.978B 0.00
Collegium Pharmaceutical (COLL) United States $0.950B 5.12
Enliven Therapeutics (ELVN) United States $0.933B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.927B 0.00
Ardelyx (ARDX) United States $0.845B 0.00
Cronos Group (CRON) Canada $0.790B 0.00
Xeris Biopharma Holdings (XERS) United States $0.774B 0.00
AleAnna (ANNA) United States $0.712B 0.00
Akebia Therapeutics (AKBA) United States $0.638B 0.00
Xencor (XNCR) United States $0.624B 0.00
KalVista Pharmaceuticals (KALV) United States $0.606B 0.00
USANA Health Sciences (USNA) United States $0.559B 12.15
Bioventus (BVS) United States $0.552B 14.04
Regulus Therapeutics (RGLS) United States $0.545B 0.00
Relay Therapeutics (RLAY) United States $0.533B 0.00
Savara (SVRA) United States $0.522B 0.00
CytoDyn (CYDY) United States $0.476B 0.00
Elite Pharmaceuticals (ELTP) United States $0.465B 0.00
Altimmune (ALT) United States $0.463B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.440B 0.00
Siga Technologies (SIGA) United States $0.424B 8.87
Zevra Therapeutics (ZVRA) United States $0.424B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.410B 0.00
Tourmaline Bio (TRML) United States $0.405B 0.00
Verve Therapeutics (VERV) United States $0.388B 0.00
Organogenesis (ORGO) United States $0.379B 0.00
Oruka Therapeutics (ORKA) United States $0.365B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.333B 8.99
Heron Therapeutics (HRTX) United States $0.313B 0.00
Aquestive Therapeutics (AQST) United States $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.265B 24.48
ProKidney (PROK) United States $0.220B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Avita Medical (RCEL) United States $0.192B 0.00
Liminatus Pharma (LIMN) $0.185B 0.00
Wellgistics Health (WGRX) United States $0.184B 0.00
OmniAb (OABI) United States $0.175B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Inhibikase Therapeutics (IKT) United States $0.163B 0.00
Esperion Therapeutics (ESPR) United States $0.158B 0.00
Journey Medical (DERM) United States $0.158B 0.00
Nanobiotix S.A (NBTX) France $0.157B 0.00
4D Molecular Therapeutics (FDMT) United States $0.154B 0.00
Korro Bio (KRRO) United States $0.150B 0.00
Aclaris Therapeutics (ACRS) United States $0.135B 0.00
Larimar Therapeutics (LRMR) United States $0.133B 0.00
Nektar Therapeutics (NKTR) United States $0.133B 0.00
Aldeyra Therapeutics (ALDX) United States $0.132B 0.00
Profound Medical (PROF) Canada $0.129B 0.00
Protara Therapeutics (TARA) United States $0.126B 0.00
Lyell Immunopharma (LYEL) United States $0.125B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.123B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.119B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.118B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
VAXART, INC (VXRT) United States $0.092B 0.00
Cassava Sciences (SAVA) United States $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.088B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Lexeo Therapeutics (LXEO) United States $0.087B 0.00
Achieve Life Sciences (ACHV) Canada $0.086B 0.00
Dominari Holdings (DOMH) United States $0.086B 0.00
Fractyl Health (GUTS) United States $0.084B 0.00
Champions Oncology (CSBR) United States $0.083B 13.64
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.079B 58.56
Inotiv (NOTV) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Context Therapeutics (CNTX) United States $0.070B 0.00
Unicycive Therapeutics (UNCY) United States $0.068B 0.00
Nutriband (NTRB) United States $0.065B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Karyopharm Therapeutics (KPTI) United States $0.053B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
PMV Pharmaceuticals (PMVP) United States $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.043B 0.00
Prelude Therapeutics (PRLD) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Surrozen (SRZN) United States $0.026B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Mannatech (MTEX) United States $0.023B 9.00
BioVie (BIVI) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
DURECT (DRRX) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.58
Plus Therapeutics (PSTV) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00